Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance
title

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits

 

escrs app advert yo advert

ICR implantation in the treatment of irregular cornea in keratoconus before cataract surgery

Search Title by author or title

Session Details

Session Title: Cataract Surgery Special Cases

Session Date/Time: Monday 12/09/2016 | 08:00-10:30

Paper Time: 08:12

Venue: Auditorium C6

First Author: : E.Coskunseven TURKEY

Co Author(s): :    A. Koc Akbay   O. Sahin   I. Pallikaris              

Abstract Details

Purpose:

To evaluate the refractive and topographic results of the ICR implantation in the treatment of Irregular Cornea in Keratoconus before Cataract Surgery.

Setting:

Dunya Eye Hospital Istanbul Turkey

Methods:

In this prospective case series, 4 patients (8 eyes) with keratoconus and cataract were included. None of the patients were not suitable for contact lens. The mean age was 56 (52-64) All patients underwent intracorneal ring segments implantation, followed by Facoemulsification and Intraocular Lens implantation Cataract Surgery. The follow-up period was 12 months after the last procedure for all patients. Time interval between intracorneal ring segments implantation and Facoemulsification and Intraocular Lens implantation Cataract Surgery was 6 months.

Results:

The mean Flat K value decreased from 50,2 to 49.3 and the steep K value decreased from 56,6 to 52.2, the mean corneal astigmatism decreaseed from 6.4 to 2.9 after ICR implantation. LogMAR mean uncorrected distance visual acuity and mean corrected distance visual acuity improved from 0,02±0,01 and 0.15±0.2 preoperatively, to 0.68±0.07 and 0.72±0.04 after the completion of the 2-step procedure, respectively.

Conclusions:

Intracorneal ring segments implantation followed by facoemulsification and Intraocular Lens implantation Cataract Surgery; 2-step procedure seems to be an effective treatment in Keratoconus with highly irregular cornea and cataract patients.

Financial Disclosure:

NONE

Back to previous